[Should inoperable pulmonary cancer be treated?].
Our review analyses the rationale for chemotherapy in inoperable non small cell lung cancer. We concluded that such a treatment might be beneficial in about 30% of the patients. It is however a potentially toxic approach; the inconveniences can be reduced by a close follow-up and the use of various techniques of supportive care.
Klastersky
J
J
Service de Médecine, Institut Jules Bordet, Bruxelles.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000191:economics / Q000401:mortality / Q000628:therapy*; D003131:Combined Modality Therapy; D017281:Cost of Illness; D006801:Humans; D008175:Lung Neoplasms / Q000191:economics / Q000401:mortality / Q000628:therapy*; D010166:Palliative Care; D011879:Radiotherapy Dosage